Skip to content
Screener

Sionna Therapeutics SION Q2 2025 earnings

Reported August 11, 2025 · Before market open

EPS-$0.41Beat by $0.27
EPS estimate-$0.68

Next report

Nov 4, 2026 (in 2 months)
EPS estimate-$0.64

Financials

Q2 2025

Income statement

See full
Operating income-$21.9M-94.0%
Net income-$18.1M-111%
EPS (diluted)-$410.00+84.9%

Balance sheet

See full
Cash & equivalents$41.9M-6.8%
Total debt$9.2M—
Total equity$336.4M+351%
Total assets$352.0M—

Cash flow

See full
Operating cash flow-$18.2M-78.9%
CapEx-—
Free cash flow-$18.2M-78.9%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$707.24M—
Enterprise value$674.53M—

Returns & leverage

See full
Debt / equity0×—
Current ratio35.3×—

FAQ

When did Sionna Therapeutics report Q2 2025 earnings?
Sionna Therapeutics (SION) reported Q2 2025 earnings on August 11, 2025 before market open.
What were Sionna Therapeutics's Q2 2025 revenue and EPS?
Sionna Therapeutics reported eps of $-0.41 for Q2 2025.
Did Sionna Therapeutics beat estimates in Q2 2025?
EPS beat the consensus estimate of $-0.68 by $0.27.
How did Sionna Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 55.4% from $-0.92.
Where can I find Sionna Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0002036042-25-000044) and the 10-Q periodic report (0002036042-25-000047) directly on SEC EDGAR. The filing index links above go to sec.gov.